NCT02866851 Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy Status TERMINATED Phase NA
NCT02860481 FSH-R : Diagnostic Application for Localized Tumors in Cancerology Status TERMINATED Phase NA
NCT02857114 Measuring the Effects of Touch Relaxation Painful Patients in Oncologie Nursing Status UNKNOWN Phase NA
NCT02856048 Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT02852473 Impact of Continuous Positive Airway Pressure on Breathing Motion Amplitude Status COMPLETED Phase EARLY_PHASE1
NCT02850640 Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02849041 Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells Status UNKNOWN Phase NA
NCT02847715 Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences Status COMPLETED Phase NA
NCT02846766 Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling Status WITHDRAWN Phase PHASE2
NCT02843763 Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer Status UNKNOWN Phase NA
NCT02840058 Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1 Status COMPLETED Phase NA
NCT02839889 Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) Status TERMINATED Phase PHASE4
NCT02836392 CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey Status COMPLETED Phase N/A
NCT02836288 Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02834611 Ceramide NanoLiposome in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02832167 An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread Status COMPLETED Phase PHASE2
NCT02830061 The Experience of TYAC Offered Ovarian Tissue Cryopreservation Status COMPLETED Phase N/A